The global bone and joint health Supplements market size is estimated to reach USD 27.16 billion by 2033, registering a CAGR of 7.57% from 2025 to 2033, according to a new report by Grand View Research, Inc. Increasing prevalence of orthopedic disorders among the geriatric and adult population is one of the major factors driving the market. According to the CDC, around 58.5 million people are diagnosed with arthritis and it is more common in women as compared to men. Also, the increasing burden of arthritis is anticipated to drive the industry during the forecast period. As per the CDC, around 78.4 million adults aged 18 years and above are anticipated to be diagnosed with arthritis. Moreover, the rising geriatric population across the globe is fueling industry growth as the prevalence of orthopedic disorders increases with age. Around 49.6% of people aged above 65 years are diagnosed with arthritis.
Furthermore, the rising health consciousness, increasing consumer interest in active living, and rising disposable income are among the key factors driving the industry. In addition, increasing awareness regarding micronutrient deficiencies, increasing access to supplements, availability of multiple products, and the increasing number of distribution channels are supporting the growth.
Moreover, the increasing focus of key companies on various strategies to meet consumer demand is impelling market growth. For instance, in March 2022, Bioiberica entered into a partnership with ByHealth to develop a product for joint health brand “Highflex” in the China market. Furthermore, the manufacturers are developing new supplements in various formulations to attract the consumer base, thereby positively impacting the industry's growth. For instance, in February 2022, Gadot Biochemical Industries launched ‘Cal2Mag’, a new mineral blend combining calcium and magnesium, to specifically target bone health.
Request a free sample copy or view report summary: Bone And Joint Health Supplements Market Report
By product, the vitamin product segment dominated the market in 2024, due to the increasing prevalence of vitamin D deficiency in children and adults. This, in turn, is raising the demand for vitamin supplements to support bone and joint health.
By formulation, the capsule segment is expected to grow at a significant CAGR throughout the forecast period, owing to its high preference due to the ease of consumption.
Based on application, the bone density support segment held a significant revenue share of over 20% in 2024, driven by the rising focus on preventive healthcare and proactive wellness.
Based on consumer group, the geriatric segment is expected to grow fastest over the forecast period, owing to the increasing prevalence of arthritis and osteoporosis among the geriatric population and the rising incidence of bone fractures due to osteoporosis.
By sales channel, the bricks and mortar segment held the largest share in 2024, owing to the presence of a large number of providers, lucrative discounts, and high.
North America dominated the market in 2024, due to the increasing number of people suffering from joint disorders and rising awareness regarding healthy and active lifestyle.
Grand View Research has segmented the global bone and joint health supplements market based on product, application, formulation, consumer group, sales channel, and region:
Bone & Joint Health Supplements Product Outlook (Revenue, USD Million, 2021 - 2033)
Vitamins
Minerals
Collagen
Omega-3
Glucosamine
Others
Bone & Joint Health Supplements Formulation Outlook (Revenue, USD Million, 2021 - 2033)
Capsules
Tablets
Powders
Softgels
Others
Bone & Joint Health Supplements Application Outlook (Revenue, USD Million, 2021 - 2033)
Bone Density Support
Bone Strength Support
Mobility & Physical Function
Muscle Health & Recovery
Performance Enhancement (Sports & Endurance)
Pain Relief & Inflammation Management
Bone & Joint Health Supplements Consumer Group Outlook (Revenue, USD Million, 2021 - 2033)
Infants
Children
Adults
Pregnant Women
Geriatric Population
Bone & Joint Health Supplements Sales Channel Outlook (Revenue, USD Million, 2021 - 2033)
Bricks and Mortar
Direct Selling
Chemists/Pharmacies
Health Food Shops
Hypermarkets
Supermarkets
E-commerce
Bone & Joint Health Supplements Regional Outlook (Revenue, USD Million, 2021 - 2033)
North America
U.S.
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
China
India
Japan
South Korea
Australia
Thailand
Taiwan
Malaysia
Latin America
Brazil
Argentina
Middle East and Africa (MEA)
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players in the Bone & Joint Health Supplements Market
Herbalife International of America, Inc.
GNC Holdings, LLC
Nature's Bounty
Amway
Garden of Life
Thorne.
Solgar Inc.
Pure Encapsulations, LLC.
Glanbia plc
NOW Foods
"The quality of research they have done for us has been excellent..."